Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Asset Writedowns and Impairment (2016 - 2025)

Healthstream (HSTM) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with $408000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 31.43% to $408000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 61.16% decrease, with the full-year FY2025 number at $1.0 million, down 61.16% from a year prior.
  • Asset Writedowns and Impairment was $408000.0 for Q4 2025 at Healthstream, up from $200000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.6 million in Q2 2024 to a low of -$139000.0 in Q2 2021.
  • A 5-year average of $289100.0 and a median of $200000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 320.63% in 2021, then surged 3233.33% in 2023.
  • Healthstream's Asset Writedowns and Impairment stood at $624000.0 in 2021, then plummeted by 102.4% to -$15000.0 in 2022, then surged by 2240.0% to $321000.0 in 2023, then surged by 85.36% to $595000.0 in 2024, then tumbled by 31.43% to $408000.0 in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Asset Writedowns and Impairment are $408000.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025).